Chemokine expression profile of freshly isolated human glioblastoma-associated macrophages/microglia

Hattermann,Kirsten; Sebens,Susanne; Helm,Ole; Schmitt,Anne   Dorothée; Mentlein,Rolf; Mehdorn,H.  Maximilian; Held-Feindt,Janka

doi:10.3892/or.2014.3214

Chemokine expression profile of freshly isolated human glioblastoma-associated macrophages/microglia

Authors:
- Kirsten Hattermann
- Susanne Sebens
- Ole Helm
- Anne Dorothée Schmitt
- Rolf Mentlein
- H. Maximilian Mehdorn
- Janka Held-Feindt
View Affiliations

Affiliations: Department of Anatomy, University of Kiel, D-24098 Kiel, Germany, Institute for Experimental Medicine, Inflammatory Carcinogenesis, University Medical Center Schleswig-Holstein UKSH, Campus Kiel, D-24105 Kiel, Germany, Department of Neurosurgery, University Medical Center Schleswig-Holstein UKSH, Campus Kiel, D-24105 Kiel, Germany
Published online on: May 23, 2014 https://doi.org/10.3892/or.2014.3214
Pages: 270-276

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Several studies have substantiated the hypothesis that tumor progression is not only driven by the tumor cells themselves but also by their interaction with intrinsic and surrounding stromal cells. Tumor-associated macrophages and microglial cells (TAMs) represent one major stromal cell component of glioblastomas. Additionally, in many gliomas, chemokines are highly expressed and some chemokines were already linked to settlement of TAMs in tumors. However, although chemoattraction mechanisms mediated by chemokines and their receptors are well documented, information on their expression and role in TAMs, particularly in patients, is limited. Therefore, we investigated the transcription of the chemokine-receptor combinations CXCL12-CXCR4-CXCR7, CXCL16-CXCR6 and CX3CL1-CX3CR1 in freshly isolated TAMs from 20 human glioblastomas in relation to in vitro polarized M1- and M2-macrophages. We demonstrated that TAMs express both M1- and M2-markers. Compared to in vitro polarized macrophages, the M1-marker interleukin (IL)-6 was similarly expressed, whereas IL-1β and tumor necrosis factor (TNF)-α were found at lower levels. The M2-marker IL-10 was comparably expressed, while CD163 and transforming growth factor (TGF)-β were detected with one tenth lower intensities in TAMs. All investigated chemokines/receptors were transcribed at moderate to high levels in TAMs as well as in vitro polarized macrophages. However, CX3CR1 was markedly higher and CXCR7 was somewhat higher expressed in TAMs, whereas M2-macrophages were characterized by the highest CXCL12 and a moderate CX3CL1 expression. Collectively, TAMs share properties of M1- and M2-macrophages and show a considerably higher expression of the chemokine receptors CXCR7 and CX3CR1.

View Figures

View References

1	Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C and Flavell RA: Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 13:759–771. 2013. View Article : Google Scholar : PubMed/NCBI
2	Ohgaki H and Kleihues P: Epidemiology and ethiology of gliomas. Acta Neuropathol. 109:93–108. 2005. View Article : Google Scholar : PubMed/NCBI
3	Badie B and Schartner JM: Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. Neurosurgery. 46:957–961. 2000.PubMed/NCBI
4	Li W and Graber MB: The molecular profile of microglia under the influence of glioma. Neuro Oncol. 14:958–978. 2012. View Article : Google Scholar : PubMed/NCBI
5	Markovic DS, Glass R, Synowitz M, Rooijen Nv and Kettenmann H: Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J Neuropathol Exp Neurol. 64:754–762. 2005. View Article : Google Scholar : PubMed/NCBI
6	Zhai H, Heppner FL and Tsirka SE: Microglia/macrophages promote glioma progression. Glia. 59:472–485. 2011. View Article : Google Scholar : PubMed/NCBI
7	Mantovani A, Germano G, Marchesi F, Locatelli M and Biswas SK: Cancer-promoting tumor-associated macrophages: new vistas and open questions. Eur J Immunol. 41:2522–2525. 2011. View Article : Google Scholar : PubMed/NCBI
8	Kielian T, van Rooijen N and Hickey WF: MCP-1 expression in CNS-1 astrocytoma cells: implications for macrophage infiltration into tumors in vivo. J Neurooncol. 56:1–12. 2002. View Article : Google Scholar : PubMed/NCBI
9	Galasso JM, Stegman LD, Blaivas M, Harrison JK, Ross BD and Silverstein FS: Experimental gliosarcoma induces chemokine receptor expression in rat brain. Exp Neurol. 161:85–95. 2000. View Article : Google Scholar : PubMed/NCBI
10	Okada M, Saio M, Kito Y, Ohe N, Yano H, Yoshimura S, Iwama T and Takami T: Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1. Int J Oncol. 34:1621–1627. 2009.PubMed/NCBI
11	Held-Feindt J, Hattermann K, Müerköster SS, Wedderkopp H, Knerlich-Lukoschus F, Ungefroren H, Mehdorn HM and Mentlein R: CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs). Exp Cell Res. 316:1553–1566. 2010. View Article : Google Scholar : PubMed/NCBI
12	Hattermann K and Mentlein R: An infernal trio: the chemokine CXCL12 and its receptors CXCR4 and CXCR7 in tumor biology. Ann Anat. 195:103–110. 2013. View Article : Google Scholar : PubMed/NCBI
13	Hattermann K, Held-Feindt J, Ludwig A and Mentlein R: The CXCL16-CXCR6 axis in glial tumors. J Neuroimmunol. 260:47–54. 2013. View Article : Google Scholar : PubMed/NCBI
14	Hattermann K1, Held-Feindt J, Lucius R, Müerköster SS, Penfold ME, Schall TJ and Mentlein R: The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Res. 70:3299–3308. 2010. View Article : Google Scholar : PubMed/NCBI
15	Hattermann K, Ludwig A, Gieselmann V, Held-Feindt J and Mentlein R: The chemokine CXCL16 induces migration and invasion of glial precursor cells via its receptor CXCR6. Mol Cell Neurosci. 39:133–141. 2008. View Article : Google Scholar : PubMed/NCBI
16	Domanska UM, Kruizinga RC, den Dunnen WF, Timmer-Bosscha H, de Vries EG and Walenkamp AM: The chemokine network, a newly discovered target in high grade gliomas. Crit Rev Oncol Hematol. 79:154–163. 2011. View Article : Google Scholar : PubMed/NCBI
17	Sciumè G, Santoni A and Bernardini G: Chemokines and glioma: invasion and more. J Neuroimmunol. 224:8–12. 2010.PubMed/NCBI
18	Grage-Griebenow E, Zwatzky R, Kahlert H, Brade L, Flad H and Ernst E: Identification of a novel dendritic cell-like subset of CD64⁺/CD16⁺ blood monocytes. Eur J Immunol. 31:48–56. 2001. View Article : Google Scholar : PubMed/NCBI
19	Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N, Hussell T, Feldmann M and Udalova IA: IRF5 promotes inflammatory macrophages polarization and T_H1–T_H17 responses. Nat Immunol. 12:231–238. 2011. View Article : Google Scholar : PubMed/NCBI
20	Verreck FA1, de Boer T, Langenberg DM, van der Zanden L and Ottenhoff TH: Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-γ- and CD40L-mediated costimulation. J Leukoc Biol. 79:285–292. 2006.PubMed/NCBI
21	Schäfer H, Struck B, Feldmann EM, Bergmann F, Grage-Griebenow E, Geismann C, Ehlers S, Altevogt P and Sebens S: TGF-β1-dependent L1CAM expression has an essential role in macrophage-induced apoptosis resistance and cell migration of human intestinal epithelial cells. Oncogene. 32:180–189. 2013.
22	Kennedy BC, Showers CR, Anderson DE, Anderson L, Canoll P, Bruce JN and Anderson RCE: Tumor-associated macrophages in glioma: friend or foe? J Oncol. 2013:4869122013. View Article : Google Scholar : PubMed/NCBI
23	Ruffel B, Affara NI and Coussens LM: Differential macrophage programming in the tumor microenvironment. Trends Immunol. 33:119–126. 2012. View Article : Google Scholar : PubMed/NCBI
24	Miller RJ, Rostene W, Apartis E, Banisadr G, Biber K, Milligan ED, White FA and Zhang J: Chemokine action in the nervous system. J Neurosci. 28:11792–11795. 2008. View Article : Google Scholar : PubMed/NCBI
25	Vandercappellen J, Van Damme J and Struyf S: The role of CXC chemokines and their receptors in cancer. Cancer Lett. 267:226–244. 2008. View Article : Google Scholar : PubMed/NCBI
26	Kakinuma T and Hwang ST: Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol. 79:639–651. 2006. View Article : Google Scholar : PubMed/NCBI
27	Zlotnik A: Chemokines and cancer. Int J Cancer. 119:2026–2029. 2006. View Article : Google Scholar : PubMed/NCBI
28	Lu H, Ouyang W and Huang C: Inflammation, a key event in cancer development. Mol Cancer Res. 4:221–233. 2006. View Article : Google Scholar : PubMed/NCBI
29	Ben-Baruch A: The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev. 25:357–371. 2006. View Article : Google Scholar : PubMed/NCBI
30	Platten M, Kretz A, Naumann U, Aulwurm S, Egashira K, Isenmann S and Weller M: Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas. Ann Neurol. 54:388–392. 2003. View Article : Google Scholar : PubMed/NCBI
31	Allavena P, Sica A, Solinas G, Porta C and Mantovani A: The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol. 66:1–9. 2008. View Article : Google Scholar : PubMed/NCBI
32	Sica A, Schioppa T, Mantovani A and Allavena P: Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer. 42:717–727. 2006. View Article : Google Scholar
33	Helm O, Held-Feindt J, Grage-Griebenow E, Reiling N, Ungefroren H, Vogel I, Krüger U, Becker T, Ebsen M, Röcken C, Kabelitz D, Schäfer H and Sebens S: Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis. Int J Cancer. Jan 23–2014.(Epub ahead of print). View Article : Google Scholar
34	Arenberg DA, Keane MP, DiGiovine B, Kunkel SL, Strom SR, Burdick MD, Iannettoni MD and Strieter RM: Macrophage infiltration in human non-small-cell lung cancer: the role of CC chemokines. Cancer Immunol Immunother. 49:63–70. 2000. View Article : Google Scholar : PubMed/NCBI
35	Balkwill F: Cancer and the chemokine network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar
36	Mantovani A, Allavena P, Sozzani S, Vecchi A, Locati M and Sica A: Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors. Semin Cancer Biol. 14:155–160. 2004. View Article : Google Scholar : PubMed/NCBI
37	Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, Koike M, Inadera H and Matsushima K: Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res. 6:3282–3289. 2000.PubMed/NCBI
38	Monti P, Leone BE, Marchesi F, Balzano G, Zerbi A, Scaltrini F, Pasquali C, Calori G, Pessi F, Sperti C, Di Carlo V, Allavena P and Piemonti L: The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity. Cancer Res. 63:7451–7461. 2003.PubMed/NCBI
39	Bachleder RE, Wendt MA and Mercurio AM: Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 62:7203–7206. 2002.PubMed/NCBI
40	Schioppa T, Uranchimeg B, Saccani A, Biswas SK, Doni A, Rapisarda A, Bernasconi S, Saccani S, Nebuloni M, Vago L, Mantovani A, Melillo G and Sica A: Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med. 198:1391–1402. 2003. View Article : Google Scholar : PubMed/NCBI
41	Schutyser E, Struyf S, Proost P, Opdenakker G, Laureys G, Verhasselt B, Peperstraete L, Van de Putte I, Saccani A, Allavena P, Mantovani A and Van Damme J: Identification of biologically active chemokine isoforms from ascetic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma. J Biol Chem. 277:24584–24593. 2002. View Article : Google Scholar
42	Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P and Mantovani A: Macrophage polarization in tumor progression. Semin Cancer Biol. 18:349–355. 2008. View Article : Google Scholar
43	Biswas SK, Gangi L, Paul S, Schioppa T, Saccani A, Sironi M, Bottazzi B, Doni A, Vincenzo B, Pasqualini F, Vago L, Nebuloni M, Mantovani A and Sica A: A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation). Blood. 107:2112–2122. 2006.PubMed/NCBI
44	Pyonteck SM, Akkari L, Schuhmacher AJ, Bowman RL, Sevenich L, Quail DF, Olson OC, Quick ML, Huse JT, Teijeiro V, Setty M, Leslie CS, Oei Y, Pedraza A, Zhang J, Brennan CW, Sutton JC, Holland EC, Daniel D and Joyce JA: CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med. 19:1264–1272. 2013. View Article : Google Scholar : PubMed/NCBI
45	Pong WW, Walker J, Wylie T, Magrini V, Luo J, Emnett RJ, Choi J, Cooper ML, Griffith M, Griffith OL, Rubin JB, Fuller GN, Piwnica-Worms D, Feng X, Hambardzumyan D, DiPersio JF, Mardis ER and Gutmann DH: F11R is a novel monocyte prognostic biomarker for malignant glioma. PLoS One. e775712013. View Article : Google Scholar : PubMed/NCBI
46	Ye XZ, Xu SL, Xin YH, Yu SC, Ping YF, Chen L, Xiao HL, Wang B, Yi L, Wang QL, Jiang XF, Yang L, Zhang P, Qian C, Cui YH, Zhang X and Bian XW: Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway. J Immunol. 189:444–453. 2012.PubMed/NCBI